![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, September 21, 2015 10:17:47 PM
FDA approval for ALF is minimum 3 years away and surgibot will never make it to make and if it does, hospitals will have to buy 2 systems and take up twice the space if they buy ALF and Surgibot - cost prohibitive and will gain no traction.
Good thing TITXF will be a single port and multi-port in one surgical robotic system.
TRXC was once $14/share now trading at $2.60/share and appears to be heading down with this acquisition since neither of these products are FDA approved. Go check out how much revenue ALF has since they got CE mark 10 years ago.
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM